GlassScriptPhysician profile
Marcus Samuel Davis
NPI 1780114504
$1,013.03
in general payments reported to CMS, 2019-2025
10 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.15 · 2020: $31.37 · 2022: $287 · 2023: $313 · 2024: $108 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $479.71 | 2022-2025 | Exalt Model D, Resolution 360 Clip, Axios |
| Regeneron Healthcare Solutions, INC. | $119.48 | 2023-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $109.01 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.81 | 2022 | |
| Alexion Pharmaceuticals, INC. | $67.01 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.05 | 2019 | |
| Janssen Biotech, INC. | $27.43 | 2025 | Tremfya, Simponi Aria, Simponi |
| Olympus America INC. | $19.42 | 2025 | Endoclot Sis, Endoclot Phs |
| Braintree Laboratories, INC. | $18.01 | 2023 | Suflave |
| Novo Nordisk INC | $14.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.